Lymphokine-activated killer cells, natural killer cells and cytokines.

In the past year, natural killer cells have been the subject of much active investigation. The analysis of the effect of cytokines on the generation, proliferation and function of natural killer cells, and the definition of the lymphokines that they produce, have been particularly important areas of research in view of their possible application in adaptive immunotherapy, combined with biological response modifiers.

[1]  G. Trinchieri,et al.  Production of hematopoietic colony-stimulating factors by human natural killer cells , 1989, The Journal of experimental medicine.

[2]  E. Unanue,et al.  Tumor necrosis factor is involved in the T cell-independent pathway of macrophage activation in scid mice. , 1989, Journal of immunology.

[3]  U. Dianzani,et al.  CD8+CD11b+ peripheral blood T lymphocytes contain lymphokine‐activated killer cell precursors , 1989, European journal of immunology.

[4]  Craig W. Reynolds,et al.  The proliferation and life‐span of rat large granular lymphocytes: effects of cytokines , 1989, European journal of immunology.

[5]  T. Honjo,et al.  Interleukin 5 enhances interleukin 2-mediated lymphokine-activated killer activity , 1989, The Journal of experimental medicine.

[6]  J. Banchereau,et al.  Tumor necrosis factor-alpha strongly potentiates interleukin-3 and granulocyte-macrophage colony-stimulating factor-induced proliferation of human CD34+ hematopoietic progenitor cells. , 1990 .

[7]  H. Masutani,et al.  Mitogenicity and down-regulation of high-affinity interleukin 2 receptor by YTA-1 and YTA-2, monoclonal antibodies that recognize 75-kDa molecules on human large granular lymphocytes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. Thompson,et al.  Induction of lymphokine-activated killer activity by interleukin 4 in human lymphocytes preactivated by interleukin 2 in vivo or in vitro. , 1989, Cancer research.

[9]  M. Bennett,et al.  Resistance to Mycoplasma pulmonis mediated by activated natural killer cells. , 1990, The Journal of infectious diseases.

[10]  J. Ortaldo,et al.  Mechanisms of target cell killing by natural killer cells. , 1989, Current opinion in immunology.

[11]  K. Sugamura,et al.  Increased expression of the interleukin 2 (IL-2) receptor beta chain (p70) on CD56+ natural killer cells after in vivo IL-2 therapy: p70 expression does not alone predict the level of intermediate affinity IL- 2 binding , 1990, The Journal of experimental medicine.

[12]  L. Lanier,et al.  Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis , 1986, The Journal of experimental medicine.

[13]  M. V. D. van den Brink,et al.  The generation of natural killer (NK) cells from NK precursor cells in rat long-term bone marrow cultures , 1990, The Journal of experimental medicine.

[14]  E. Hersh,et al.  Tumor targets stimulate IL-2 activated killer cells to produce interferon-gamma and tumor necrosis factor. , 1989, Journal of immunology.

[15]  C. Figdor,et al.  IL-4 inhibits IL-2-mediated induction of human lymphokine-activated killer cells, but not the generation of antigen-specific cytotoxic T lymphocytes in mixed leukocyte cultures. , 1988, Journal of immunology.

[16]  H. Young,et al.  Interleukin 2-induced proliferation of murine natural killer cells in vivo , 1990, The Journal of experimental medicine.

[17]  G. Trinchieri,et al.  Biology of Natural Killer Cells , 1989, Advances in Immunology.

[18]  F. Podlaski,et al.  Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[19]  S. Ferrini,et al.  Immunotherapy and immunity to cancer: cellular mechanisms. , 1989, Current opinion in immunology.

[20]  J. Xiao,et al.  Target cell-directed inactivation and IL-2-dependent reactivation of LAK cells. , 1989, Cellular immunology.

[21]  E. A. Havell Evidence that tumor necrosis factor has an important role in antibacterial resistance. , 1989, Journal of immunology.

[22]  C. Biron,et al.  Cyclosporin A inhibition of interleukin 2 gene expression, but not natural killer cell proliferation, after interferon induction in vivo , 1990, The Journal of experimental medicine.

[23]  J. Blay,et al.  Involvement of cyclic adenosine monophosphate in the interleukin 4 inhibitory effect on interleukin 2-induced lymphokine-activated killer generation. , 1990, The Journal of clinical investigation.

[24]  G. Trinchieri,et al.  Inactivation of natural killer cell cytotoxic activity after interaction with target cells. , 1981, Journal of immunology.

[25]  J. D. Young Killing of target cells by lymphocytes: a mechanistic view. , 1989, Physiological reviews.

[26]  D. Yuan,et al.  Regulation of B lymphocytes by natural killer cells. Role of IFN-gamma. , 1989, Journal of immunology.

[27]  G. Trinchieri,et al.  Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes , 1989, Journal of Experimental Medicine.

[28]  G. Trinchieri,et al.  Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers , 1991, The Journal of experimental medicine.

[29]  T. Miyawaki,et al.  Interleukin 3 enhanced interleukin 2-dependent maturation of NK progenitor cells in bone marrow from mice with severe combined immunodeficiency. , 1989, Cellular immunology.

[30]  M. Caligiuri,et al.  Fc gamma receptor type III (CD16) is included in the zeta NK receptor complex expressed by human natural killer cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[31]  G. Trinchieri,et al.  Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon , 1985, The Journal of experimental medicine.

[32]  G. Bosma,et al.  Transplantable progenitors of natural killer cells are distinct from those of T and B lymphocytes. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[33]  G. Trinchieri,et al.  Inhibition of bone marrow colony formation by human natural killer cells and by natural killer cell-derived colony-inhibiting activity , 1985, The Journal of experimental medicine.

[34]  G. Trinchieri,et al.  Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells , 1988, The Journal of experimental medicine.

[35]  G. Trinchieri,et al.  Fc gamma R(CD16) interaction with ligand induces Ca2+ mobilization and phosphoinositide turnover in human natural killer cells. Role of Ca2+ in Fc gamma R(CD16)-induced transcription and expression of lymphokine genes , 1989, The Journal of experimental medicine.

[36]  L. Lanier,et al.  Comparative studies of human FcRIII-positive and negative natural killer cells. , 1989, Journal of immunology.

[37]  G. Trinchieri,et al.  Induction of proliferation in vitro of resting human natural killer cells: IL 2 induces into cell cycle most peripheral blood NK cells, but only a minor subset of low density T cells. , 1986, Journal of immunology.

[38]  L. Lanier,et al.  Natural killer cells: definition of a cell type rather than a function. , 1986, Journal of immunology.

[39]  B. Kwon,et al.  Induction of perforin and serine esterases in a murine cytotoxic T lymphocyte clone. , 1990, Journal of immunology.

[40]  M. V. D. van den Brink,et al.  Lymphokine-activated killer cells in rats: generation of natural killer cells and lymphokine-activated killer cells from bone marrow progenitor cells. , 1989, Cellular immunology.

[41]  T. Luger,et al.  IFN-beta 2/IL-6 augments the activity of human natural killer cells. , 1989, Journal of immunology.

[42]  Masakazu,et al.  Expansion of natural killer cells but not T cells in human interleukin 2/interleukin 2 receptor (Tac) transgenic mice , 1989, The Journal of experimental medicine.

[43]  G. Trinchieri,et al.  Preferential proliferation of natural killer cells among peripheral blood mononuclear cells cocultured with B lymphoblastoid cell lines. , 1987, Natural immunity and cell growth regulation.

[44]  F. Malavasi,et al.  Ultrastructural analysis of human natural killer cell activation. , 1987, Blood.

[45]  K. Sugamura,et al.  Activation of natural killer cells via the p75 interleukin 2 receptor , 1989, The Journal of experimental medicine.